nach oben

Acta Diabetologica

Erschienen in:

27.04.2019 | Original Article

Connexin43 hemichannel block protects against retinal pigment epithelial cell barrier breakdown

verfasst von: Charisse Kuo, Colin R. Green, Ilva D. Rupenthal, Odunayo O. Mugisho

Erschienen in: Acta Diabetologica | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Aims

The retinal pigment epithelium (RPE) is an important component of the outer blood–retinal barrier (BRB) that separates the choroid from the rest of the retina. Loss of RPE-mediated BRB integrity is a key feature of diabetic macular oedema (DME), a chronic pathology resulting from diabetic retinopathy (DR). Recent studies have shown that connexin43 hemichannel opening mediates key inflammatory pathways in DR, though its effect on the barrier properties of RPE cells remains unknown. Therefore, RPE breakdown was induced by exposing a monolayer of ARPE-19 cells to high glucose (HG) and 10 ng/mL each of the pro-inflammatory cytokines IL-1β and TNF-α. The role of connexin43 hemichannels was assessed using a connexin43 hemichannel blocker, Peptide5.

Methods

Transepithelial resistance (TEER) and FITC-dextran dye leak across the ARPE-19 monolayer were used to measure RPE layer permeability. Immunohistochemistry was used to assess changes in connexin43, collagen IV and ZO-1 expression. ATP and lactate dehydrogenase (LDH) release were measured using commercially available kits.

Results

Connexin43 hemichannel block with Peptide5 prevented TEER reduction and FITC-dextran dye leak induced by a combination of HG and inflammatory cytokines. Peptide5 also blocked LDH and ATP release induced by the addition of HG and inflammatory cytokines. ZO-1 and connexin43 disruption and internalisation as well as upregulated secretion of collagen IV following HG and inflammatory cytokine exposure were also prevented. The addition of exogenous ATP into the culture medium was able to reverse Peptide5 protection against LDH release and change in connexin43 localisation, indicating that the initiating pathway in RPE disruption is connexin43 hemichannel-mediated ATP release.

Conclusion

These findings support the idea that connexin43 hemichannels may mediate RPE disruption (and its role within the BRB) that occurs in DME through an ATP release/inflammasome pathway activation dependent manner. Connexin43 hemichannels are therefore a potential therapeutic target for the treatment of DME.

Danesh-Meyer HV, Zhang J, Acosta ML, Rupenthal ID, Green CR (2016) Connexin43 in retinal injury and disease. Prog Retin Eye Res 51:41–68. https://doi.org/10.1016/j.preteyeres.2015.09.004 CrossRefPubMed

Malfait M, Gomez P, van Veen TA et al (2001) Effects of hyperglycemia and protein kinase C on connexin43 expression in cultured rat retinal pigment epithelial cells. J Membr Biol 181(1):31–40. https://doi.org/10.1007/s002320010008 CrossRefPubMed

Mori R, Power KT, Wang CHM, Martin P, Becker DL (2006) Acute downregulation of connexin43 at wound sites leads to a reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migration. J Cell Sci 119(24):5193–5203. https://doi.org/10.1242/jcs.03320 CrossRefPubMed

Oviedo-Orta E, Kwak BR, Evans WH (2013) Connexin cell communication channels: roles in the immune system and immunopathology. CRC Press, Boca RatonCrossRef

Qiu C, Coutinho P, Frank S et al (2003) Targeting connexin43 expression accelerates the rate of wound repair. Curr Biol 13(19):1697–1703CrossRef

Cheung G, Chever O, Rouach N (2014) Connexons and pannexons: newcomers in neurophysiology. Front Cell Neurosci 8:348. https://doi.org/10.3389/fncel.2014.00348 CrossRefPubMedPubMedCentral

Davidson JO, Green CR, Bennet L et al (2013) A key role for connexin hemichannels in spreading ischemic brain injury. Curr Drug Targets 14(1):36–46CrossRef

Giaume C, Leybaert L, Naus CC, Saez JC (2013) Connexin and pannexin hemichannels in brain glial cells: properties, pharmacology, and roles. Front Pharmacol 4:88. https://doi.org/10.3389/fphar.2013.00088 CrossRefPubMedPubMedCentral

Orellana JA, Martinez AD, Retamal MA (2013) Gap junction channels and hemichannels in the CNS: regulation by signaling molecules. Neuropharmacology 75:567–582. https://doi.org/10.1016/j.neuropharm.2013.02.020 CrossRefPubMed

10.

Chen YS, Green CR, Danesh-Meyer HV, Rupenthal ID (2015) Neuroprotection in the treatment of glaucoma—a focus on connexin43 gap junction channel blockers. Eur J Pharm Biopharm 95(Pt B):182–193. https://doi.org/10.1016/j.ejpb.2015.01.031 CrossRefPubMed

11.

Danesh-Meyer HV, Kerr NM, Zhang J et al (2012) Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia. Brain 135(Pt 2):506–520. https://doi.org/10.1093/brain/awr338 CrossRefPubMed

12.

Guo CX, Mat Nor MN, Danesh-Meyer HV et al (2016) Connexin43 mimetic peptide improves retinal function and reduces inflammation in a light-damaged albino rat model. Invest Ophthalmol Vis Sci 57(10):3961–3973. https://doi.org/10.1167/iovs.15-16643 CrossRefPubMed

13.

Kerr NM, Johnson CS, Zhang J, Eady EK, Green CR, Danesh-Meyer HV (2012) High pressure-induced retinal ischaemia reperfusion causes upregulation of gap junction protein connexin43 prior to retinal ganglion cell loss. Exp Neurol 234(1):144–152. https://doi.org/10.1016/j.expneurol.2011.12.027 CrossRefPubMed

14.

Zhang J, O’Carroll SJ, Danesh-Meyer HV et al (2013) Connexin based therapeutic approaches to inflammation in the central nervous system. In: Oviedo-Orta E, Kwak BR, Evans WH (eds) Connexin cell communication channels: roles in the immune system and immunopathology. CRC Press/Taylor and Francis Group, Boca Raton, pp 273–305CrossRef

15.

Olver JM (1990) Functional anatomy of the choroidal circulation: methyl methacrylate casting of human choroid. Eye (Lond) 4 (Pt 2)(2):262–272. https://doi.org/10.1038/eye.1990.38 CrossRef

16.

Simo R, Villarroel M, Corraliza L, Hernandez C, Garcia-Ramirez M (2010) The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier—implications for the pathogenesis of diabetic retinopathy. J Biomed Biotechnol 2010:190724. https://doi.org/10.1155/2010/190724 CrossRefPubMedPubMedCentral

17.

Sparrrow RJ, Hicks D, Hamel PC (2010) The retinal pigment epithelium in health and disease. Curr Mol Med 10(9):802–823CrossRef

18.

Xu H-Z, Le Y-Z (2011) Significance of outer blood–retina barrier breakdown in diabetes and ischemia. Invest Ophthalmol Vis Sci 52(5):2160–2164CrossRef

19.

Durham JT, Herman IM (2011) Microvascular modifications in diabetic retinopathy. Curr Diab Rep 11(4):253–264. https://doi.org/10.1007/s11892-011-0204-0 CrossRefPubMed

20.

Mugisho OO, Green CR, Kho DT et al (2018) The inflammasome pathway is amplified and perpetuated in an autocrine manner through connexin43 hemichannel mediated ATP release. Biochim Biophys Acta 1862(3):385–393CrossRef

21.

Mugisho OO, Rupenthal ID, Squirrell DM et al (2018) Intravitreal pro-inflammatory cytokines in non-obese diabetic mice: modelling signs of diabetic retinopathy. PLoS ONE 13(8):e0202156. https://doi.org/10.1371/journal.pone.0202156 CrossRefPubMedPubMedCentral

22.

Trudeau K, Roy S, Guo W et al (2011) Fenofibric acid reduces fibronectin and collagen type IV overexpression in human retinal pigment epithelial cells grown in conditions mimicking the diabetic milieu: functional implications in retinal permeability. Invest Ophthalmol Vis Sci 52(9):6348–6354. https://doi.org/10.1167/iovs.11-7282 CrossRefPubMedPubMedCentral

23.

Garcia-Ramírez M, Hernández C, Palomer X, Vázquez-Carrera M, Simó R (2016) Fenofibrate prevents the disruption of the outer blood retinal barrier through downregulation of NF-κB activity. Acta Diabetol 53(1):109–118CrossRef

24.

Xu HZ, Song Z, Fu S, Zhu M, Le YZ (2011) RPE barrier breakdown in diabetic retinopathy: seeing is believing. J Ocul Biol Dis Infor 4(1–2):83–92. https://doi.org/10.1007/s12177-011-9068-4 CrossRefPubMedPubMedCentral

25.

Obert E, Strauss R, Brandon C et al (2017) Targeting the tight junction protein, zonula occludens-1, with the connexin43 mimetic peptide, alphaCT1, reduces VEGF-dependent RPE pathophysiology. J Mol Med (Berl) 95(5):535–552. https://doi.org/10.1007/s00109-017-1506-8 CrossRef

26.

Aveleira CA, Lin C-M, Abcouwer SF, Ambrósio AF, Antonetti DA (2010) TNF-α signals through PKCζ/NF-κB to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes 59:2872–2882CrossRef

27.

Roy S, Maiello M, Lorenzi M (1994) Increased expression of basement membrane collagen in human diabetic retinopathy. J Clin Invest 93(1):438–442. https://doi.org/10.1172/JCI116979 CrossRefPubMedPubMedCentral

28.

Mugisho OO, Green CR, Zhang J et al (2017) Immunohistochemical characterization of connexin43 expression in a mouse model of diabetic retinopathy and in human donor retinas. Int J Mol Sci 18(12):2567. https://doi.org/10.3390/ijms18122567 CrossRefPubMedCentral

29.

Eugenin EA, Basilio D, Saez JC et al (2012) The role of gap junction channels during physiologic and pathologic conditions of the human central nervous system. J Neuroimmune Pharmacol 7(3):499–518. https://doi.org/10.1007/s11481-012-9352-5 CrossRefPubMedPubMedCentral

30.

Abderrazak A, Syrovets T, Couchie D et al (2015) NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases. Redox Biol 4:296–307. https://doi.org/10.1016/j.redox.2015.01.008 CrossRefPubMedPubMedCentral

31.

Chaurasia SS, Lim RR, Parikh BH et al (2018) The NLRP3 inflammasome may contribute to pathologic neovascularization in the advanced stages of diabetic retinopathy. Sci Rep 8(1):2847. https://doi.org/10.1038/s41598-018-21198-z CrossRefPubMedPubMedCentral

32.

Guo ZL, Yu SH, Chen X, Ye RD, Zhu WS, Liu XF (2016) NLRP3 is involved in ischemia/reperfusion injury. CNS Neurol Disord-Dr 15(6):699–712. https://doi.org/10.2174/1871527315666160321111829 CrossRef

33.

Ildefonso CJ, Biswal MR, Ahmed CM, Lewin AS (2016) The NLRP3 inflammasome and its role in age-related macular degeneration. In: Bowes Rickman C, LaVail MM, Anderson RE, Grimm C, Hollyfield J, Ash J (eds) Retinal degenerative diseases. Springer, Cham, pp 59–65CrossRef

34.

Loukovaara S, Piippo N, Kinnunen K, Hytti M, Kaarniranta K, Kauppinen A (2017) NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy. Acta Ophthalmol. https://doi.org/10.1111/aos.13427 CrossRefPubMed

Titel: Connexin43 hemichannel block protects against retinal pigment epithelial cell barrier breakdown
verfasst von: Charisse Kuo
Colin R. Green
Ilva D. Rupenthal
Odunayo O. Mugisho
Publikationsdatum: 27.04.2019
Verlag: Springer Milan
Erschienen in: Acta Diabetologica / Ausgabe 1/2020
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-019-01352-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Connexin43 hemichannel block protects against retinal pigment epithelial cell barrier breakdown

Abstract

Aims

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Aims

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Metabolomic profile of diabetic retinopathy: a GC-TOFMS-based approach using vitreous and aqueous humor

Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system

The healthy Nordic diet for blood glucose control: a systematic review and meta-analysis of randomized controlled clinical trials

Xanthine oxidoreductase activity correlates with vascular endothelial dysfunction in patients with type 1 diabetes

Titration of insulin glargine 100 U/mL when added to oral antidiabetic drugs in patients with type 2 diabetes: results of the TOP-1 real-world study

Depressive symptoms and glycaemic control in adults with type 1 diabetes: an exploratory study on the role of family functioning

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin